Professor Des Cox, Chair of the Tobacco Policy Group at the Royal College of Physicians of Ireland (RCPI), has stated that Ireland should consider raising the age limit for purchasing tobacco and nicotine inhalation products to 21 years old.
In addition to age restrictions on tobacco use, the Chairman also suggested a ban on flavored e-cigarettes and the prohibition of advertising similar products to tobacco. Discussing the Public Health (Tobacco and Nicotine Inhaling Products) Bill at the Oireachtas Health Committee, Cox explained why he believes a flavor ban is the way to go.
Compared to other age groups, teenagers are more likely to initiate nicotine inhalation products through the use of flavorings. While adults may also enjoy flavorings, the risk of initiating the use of nicotine inhalation products among teenagers and young people outweighs the benefits of using flavorings for former smokers. That's according to him.
Cox added that the theory that e-cigarettes lead to teenage smoking has been debunked by numerous scientific studies. "Research also shows that nicotine inhalation products are a gateway to tobacco smoking. Teenagers who have used nicotine inhalation products are three to five times more likely to start smoking than those who have never used such products," he said.
Taste is of utmost importance.
On the other hand, experts who aim to reduce the harms of tobacco, such as renowned cardiologist and smoking cessation researcher Dr. Konstantinos Farsalinos, have explained why taste is crucial in helping adult smokers quit. "Everyone likes flavors, from the youngest to the oldest. That's human nature. You want to have something interesting," said Dr. Farsalinos in a recent quote cited by filter.
Researchers have recently published a case for reducing tobacco harm and saving lives, which detailed the link between flavored nicotine products and successful smoking cessation. The report emphasized that flavor bans are ultimately a form of prohibition that would only fuel the development of large-scale black markets and increase smoking rates as many tobacco users would simply revert back to smoking.
In a recent episode of "Regulator Watch," Farsalinos discussed Health Canada's proposed ban, stating that evidence suggests such a ban could potentially have negative implications for public health, and that the reasoning behind the ban is likely to be flawed and could ultimately fail.
The so-called epidemic of electronic cigarettes among teenagers.
In the past, Farsalinos spoke out against the explanation of the so-called teen vaping epidemic, arguing that the premise of an increased epidemic due to e-cigarette use is flawed. He explained the risks of nicotine addiction and emphasized that the risks of e-cigarette use cannot and should not be compared to the risks of smoking. Farsalinos also added that it is the responsibility of public health officials to weigh the pros and cons of any intervention measures and determine the appropriate balance. He further stated that in the case of e-cigarettes, the benefits outweigh the risks, which must be taken into account.
Even if there is a causal relationship between e-cigarettes and subsequent smoking (which has not yet been proven, as shared responsibility is a more reasonable explanation), e-cigarettes have a minimal contribution to the prevalence of smoking. We should not forget that over the years, the use of e-cigarettes (mostly for experimentation) has increased among young people, while smoking rates have significantly declined. This is why the smoking rate data I mentioned earlier should be taken into account," he explained.
Announcement:
This article is compiled from third-party information and is intended for industry professionals for educational and informational purposes.
This article does not reflect the views of 2FIRSTS and we are unable to confirm the truthfulness and accuracy of its contents. The translation of this article is solely for industry-related communication and research purposes.
Due to limitations in the translator's abilities, the translated article may not perfectly reflect the original text. Therefore, it is advised to refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact for deletion.
Statement:
The content of this article is compiled from third-party information and is intended solely for industry exchange and learning.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness and accuracy of the content. The translation of this article is solely for industry communication and research purposes.
Due to limitations in the compiler's proficiency, the translated article may not accurately convey the original meaning. Therefore, please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any expression and position related to domestic affairs, Hong Kong, Macau, Taiwan, and foreign involvement.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
